1/4) There is a peptide proven in human randomized controlled trials to help protect against “leaky gut.”
It’s called: larazotide.
But the implications may go far beyond bloating. There’s also emerging evidence for autoimmune disease (T1D, RA), and even long COVID.
Briefly, here’s how it works.
Your intestinal lining is held together by proteins called tight junctions. Think of them as the mortar between bricks.
In response to gluten, bacteria, and inflammatory triggers, the gut releases zonulin, which opens those tight junctions and increases intestinal permeability (“leaky gut”).
Larazotide blocks this process by binding the zonulin receptor before zonulin can.